|
|
|
Volumn , Issue 4, 2010, Pages 41-44
|
|
[Effect of pneumo 23 vaccine administration in patients with chronic obstructive pulmonary disease of intermediate severity].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
23 VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;
23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;
BACTERIAL POLYSACCHARIDE;
GAMMA INTERFERON;
IL2RA PROTEIN, HUMAN;
IMMUNOGLOBULIN E;
INTERLEUKIN 2 RECEPTOR ALPHA;
PNEUMOCOCCUS VACCINE;
ACTIVE IMMUNIZATION;
ARTICLE;
BIOSYNTHESIS;
BLOOD;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
IMMUNOLOGY;
LYMPHOCYTE COUNT;
MALE;
METABOLISM;
MIDDLE AGED;
T LYMPHOCYTE;
TH1 CELL;
TREATMENT OUTCOME;
FEMALE;
HUMANS;
IMMUNOGLOBULIN E;
IMMUNOTHERAPY, ACTIVE;
INTERFERON-GAMMA;
INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT;
LYMPHOCYTE COUNT;
MALE;
MIDDLE AGED;
PNEUMOCOCCAL VACCINES;
POLYSACCHARIDES, BACTERIAL;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
T-LYMPHOCYTES;
TH1 CELLS;
TREATMENT OUTCOME;
|
|
EID: 77958163837
PISSN: 03729311
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
